YEAMAN KEVIN J

Dolby Labs CEO Kevin Yeaman sold 33,517 shares in 4 transactions for $2,240,238.36 (blended avg $66.84), reducing holdings 25.4% to 98,377 shares.

Kevin Yeaman, President and CEO of Dolby Laboratories, executed 4 separate sales totaling 33,517 (33.5K shares) for $2,240,238.36 on December 16–17, 2025, at prices ranging from $66.64 to $67.54 with a blended average of $66.84. This sale reduced his holdings from 131,894 to 98,377 shares, a net reduction of 25.4% of pre-transaction holdings. The timing is noteworthy: his prior sells at DLB have not demonstrated a pattern of well-timed exits (0 of 0 prior measurable sells at the 90-day mark were well-timed), and his broader cross-ticker track record shows a 64.29% well-timed rate on 19 prior sells with average 90-day returns of -3.0%. The current stock price of $67.14 sits 23.1% below the 52-week high of $87.32, suggesting the sales occurred during a period of weakness, though the stock is up 4.0% over the prior 30 days.

DLB CEO Kevin Yeaman sells 34,367 shares ($2.3M) in 2 transactions; holds 98,377 shares post-sale

Kevin Yeaman, President and CEO of Dolby Laboratories, executed 2 separate sales totaling 34,367 shares for $2,305,492.57 at a blended average price of $67.08 on 2025-12-09, reducing his holdings by 25.9% from 132,744 to 98,377 shares. The transaction price of $67.08 is near the current price of $67.64, placing the sale within the 52-week range of $64.55–$87.32 and 22.5% below the 52-week high. Yeaman's cross-ticker track record shows 19 prior sells with a 90-day well-timed rate of 66.67%, and at DLB specifically, 1 of 1 measurable prior sells was well-timed (30d -0.3%, 90d -9.4% on 2025-08-12), though the four most recent DLB sales remain within their measurement windows. The scale of this reduction—eliminating roughly a quarter of his position—combined with his demonstrated pattern of well-timed exits at this ticker, warrants monitoring of forward stock performance to assess whether this sale precedes material weakness.

CEO Kevin Yeaman sold 36.7K shares of DLB at $66.91; holdings drop 27.2% to 98.4K. Stock -23.3% from 52-week high.

Kevin Yeaman, as President and CEO, sold 36,699 shares on 2025-11-24 for $2,455,405.31, reducing his holdings by 27.2% from 135,076 to 98,377 shares. This is a material reduction in executive ownership at a time when the stock trades 23.3% below its 52-week high of $87.32. His prior transaction history at DLB shows a pattern of consistent selling activity: five recent trades at this ticker, all sales, with the two completed 90-day measurement windows both showing negative returns (−9.4% and −7.8%), indicating his prior sales at this ticker have been well-timed against subsequent declines. However, the transaction occurred on a date when the stock had already declined 7.1% over the prior 90 days and 0.9% over the prior 30 days, raising questions about whether this latest sale reflects forward-looking caution or simply continuation of a standing disposal program. The company's fundamentals remain solid with revenue of $315,546,000.00 in the latest quarter, net income of $46,071,000.00, annual revenue growth of +5.9%, and a P/E of 25.19—metrics that do not suggest distress but may imply valuation headwinds that executives perceive as limiting upside.

DLB CEO Kevin Yeaman sells 25,000 shares ($1.7M) in two transactions; stock down 21.9% from 52-week high.

Kevin Yeaman, President and CEO of Dolby Laboratories, executed 2 separate sales totaling 25,000 shares for $1,721,841.90 on 2025-10-14 at blended average price $68.87. This represents a -17.9% reduction in his 139,725 share pre-transaction holdings, leaving 114,725 shares post-transaction. The transaction occurred as DLB trades at $68.18 current price, down 21.9% from its 52-week high of $87.32 and -5.2% over the trailing 30 days. Yeaman's prior 5 trades at DLB show a 3-of-3 pattern of well-timed sells (90-day outcomes all negative: -7.8%, -8.7%, -8.1%), with his most recent sale on 2025-09-16 already down 4.9% within 30 days. The company's fundamentals show revenue decline of -2.0% year-over-year against a P/E of 24.88, and this latest insider sale continues a consistent pattern of selling into weakness rather than strength.

DLB CEO YEAMAN KEVIN J sold 25,000 shares at $71.66 on 2025-09-16; stock down 2.3% over 30 days post-sale

Kevin J Yeaman, President and CEO of Dolby Laboratories, executed an open-market sale of 25,000 shares on 2025-09-16 at $71.66, reducing his holdings from 139.7K to 114.7K shares (-17.9% of pre-transaction position) for total proceeds of $1.8M. The stock has since declined 2.3% over 30 days—consistent with his prior sells at DLB where 4 of 5 recent transactions preceded negative 30-day returns (ranging from -0.3% to -3.7%), though longer-term outcomes at this ticker remain unmeasurable. His broader cross-ticker track record shows 19 prior sells with a 42.86% well-timed rate and neutral 90-day average returns (-0.5%), indicating no systematic pattern of prescient exit timing. The company's fundamentals show modest headwinds: annual revenue declined 2.0% year-over-year to $315.5M, net income stands at $46.1M, and the stock trades at a 26.31 P/E, -17.4% below its 52-week high of $87.32. This sale is routine for a CEO managing a large concentrated position within a mature, stable business.

CEO Kevin Yeaman sold 25,000 DLB shares at $72.31; holds 114.7K shares post-sale. Stock -16.9% from 52-week high.

Kevin Yeaman, President and CEO of Dolby Laboratories, sold 25,000 shares on 2025-08-12 at $72.31, reducing his holdings by 17.9% to 114,725 shares. The stock is currently trading at $72.53, down 16.9% from its 52-week high of $87.32 and down 6.5% over the prior 90 days. Across his cross-ticker track record, Yeaman's 19 prior sells posted an average 90-day return of +0.7% with a 30.77% well-timed rate; however, his same-ticker history at DLB shows 5 prior sales with mixed short-term outcomes (ranging from -3.7% to +3.1% at 30 days), and no measurable 90-day results yet on which to evaluate patterns. At present, Yeaman retains a substantial position of 114.7K shares, consistent with continued stake ownership despite the sale.

DLB CEO Kevin J Yeaman sells 42,366 shares for $3.2M across 3 transactions (blended avg $74.83); holds 114,725 shares post-sale.

Kevin J Yeaman, DLB's President and CEO, executed 3 separate sales totaling 42,366 shares for $3,170,114.80 on July 15-16, 2025, reducing his holdings by 27.0% from 157,091 to 114,725 shares. The sales occurred near the stock's 52-week high of $87.32 (current price $75.62 is -13.4% from peak). Examining his prior sales at DLB specifically: 0 of 2 measurable sales were well-timed at the 90-day mark, and recent 2025 sales on June 10 and June 24 show modest negative or breakeven 30-day returns. His cross-ticker history shows a 37.50% well-timed rate on 19 prior sells, but this current filing's multi-transaction structure and the substantial -27% reduction in holdings—executed as the stock traded in the lower third of its annual range—merit investor attention to whether material business dynamics are shifting at DLB (revenue growth -2.0% annually, P/E 27.60).

CEO Kevin Yeaman sold 25,000 DLB shares at $74.02; post-sale holding 114,725 shares (-17.9%)

Kevin Yeaman, Dolby's President and CEO, sold 25,000 shares for $1,850,530.00, reducing his holdings by 17.9% to 114,725 shares. His cross-ticker track record shows 19 prior sells with a 41.18% well-timed rate (sales occurring before subsequent declines), though at Dolby specifically, 0 of 3 prior measurable sells were well-timed—each was followed by positive 90-day returns ranging from +0.5% to +1.5%. The current share price of $74.82 is 14.3% below the 52-week high, and the stock has declined 6.4% over 90 days. Dolby's fundamentals show trailing quarterly revenue of $369.6M with net income of $91.8M, but annual revenue contracted 2.0% year-over-year, creating context for a material reduction in CEO equity holdings.

CEO Kevin Yeaman sells 33,683 shares for $2,567,481.42; holdings drop 22.7% to 114,725 shares.

Kevin Yeaman, President and CEO of Dolby Laboratories, executed 2 separate sales totaling 33,683 shares for $2,567,481.42 at a blended average price of $76.22. This represents a substantial reduction in his stake, with post-transaction holdings falling 22.7% from 148,408 to 114,725 shares. The timing is notable: the stock trades at $75.23 currently, near the lower end of its 52-week range and down 13.8% from its high, yet in his prior 5 same-ticker sales at DLB, the insider was never well-timed on a 90-day horizon (0 of 5 had negative post-sale returns). His cross-ticker sell track record shows a 42.11% well-timed rate with an average 90-day return of -0.3%, suggesting neither a strong directional pattern nor conviction about downside risk at this moment. The company's fundamentals remain solid (Q-latest revenue $369,561,000.00, net income $91,793,000.00, P/E 27.46), though annual revenue growth is negative at -2.0%. This sale reflects a material reduction in insider ownership but does not clearly signal forward-looking concern given the mixed prior execution timing and stable operational metrics.

DLB CEO Kevin Yeaman sells 57,888 shares (40.9% of holdings) for $4,659,504.95 across 3 transactions

CEO Kevin Yeaman executed 3 separate sales totaling 57,888 shares for $4,659,504.95 on November 25-26, 2024, at a blended average price of $80.49, reducing his holdings by 40.9% from 141,609 to 83,721 shares. His cross-ticker track record shows a 57.14% well-timed sell rate across 16 prior sales with an average 90-day return of -1.5%, suggesting modest predictive accuracy in sale timing, though same-ticker history at DLB is mixed (2 of 3 prior measurable trades showed negative 90-day outcomes). The current stock price of $78.20 is 12.5% below the 52-week high of $89.38 and the sales occurred well above current levels, though the stock has gained 7.1% over the past 30 days and 9.3% over 90 days. The company's fundamentals show revenue growth of -2.0% year-over-year with a P/E of 28.54, indicating a relatively high valuation amid declining revenue.